Meningitis vaccine

Details Meningitis vaccine Meningitis vaccine

1980-09-22

1981-12-22

Hazel, Blondel

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

536 1, 424180, 424 88, A61K 3900, A61K 39102

Patent

active

043070809

ABSTRACT:
A high molecular weight capsular polysaccharide from H. influenza type b is an effective immunogenic agent against infection caused by the H. influenza type b bacterium.

REFERENCES:
Norden, C. W., J. of Pediatrics, vol. 80 (2), 209-214, 1972.
Felton, L. D., J. of Immunology, vol.. 74, 17-19, 1955.
Smith, D. et al., J. Clin. Invest., vol. 49, 90a, 1970.
Robbins, S., et al., Pediatrics Research, vol. 40, 376 (1970).

Affiliated with

Also associated with

Rating

Meningitis vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Meningitis vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Meningitis vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2367582